Filtered By:
Condition: Atrial Fibrillation
Infectious Disease: SARS
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 23 results found since Jan 2013.
Association between oral anticoagulants and COVID-19-related outcomes: a population-based cohort study
CONCLUSION: Among those at low baseline stroke risk, people receiving OACs had a lower risk of testing positive for SARS-CoV-2 and severe COVID-19 outcomes than non-users; this might be explained by a causal effect of OACs in preventing severe COVID-19 outcomes or unmeasured confounding, including more cautious behaviours leading to reduced infection risk.PMID:35440465 | DOI:10.3399/BJGP.2021.0689
Source: The British Journal of General Practice - April 20, 2022 Category: Primary Care Authors: Angel Ys Wong Laurie Tomlinson Jeremy P Brown William Elson Alex J Walker Anna Schultze Caroline E Morton David Evans Peter Inglesby Brian MacKenna Krishnan Bhaskaran Christopher T Rentsch Emma Powell Elizabeth Williamson Richard Croker Seb Bacon William Source Type: research
Impact of SARS ‐Cov‐2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ConclusionsOver one-fourth of HCM patients infected with SARS-Cov-2 required hospitalization, including 6% in an ICU setting. Age and cardiac features related to HCM, including baseline functional class, left ventricular outflow tract obstruction, and systolic impairment, conveyed increased risk of mortality.
Source: ESC Heart Failure - June 3, 2022 Category: Cardiology Authors: Juan R. Gimeno,
Iacopo Olivotto,
Ana Isabel Rodr íguez,
Carolyn Y. Ho,
Adrián Fernández,
Alejandro Quiroga,
Mari Angeles Espinosa,
Cristina Gómez‐González,
María Robledo,
Lucas Tojal‐Sierra,
Sharlene M. Day,
Anjali Owens,
Roberto Bar Tags: Original Article Source Type: research
Cryoballoon Pulmonary Vein Isolation as First-Line Treatment for Typical Atrial Flutter
Conclusion
Cryoballoon PVI as first-line treatment for AFL is equally effective compared with standard CTI ablation for preventing recurrence of atrial arrhythmia and better at preventing new-onset AF.
Trial registration number
NCT03401099.
Source: Heart - February 14, 2023 Category: Cardiology Authors: Gupta, D., Ding, W. Y., Calvert, P., Williams, E., Das, M., Tovmassian, L., Tayebjee, M. H., Haywood, G., Martin, C. A., Rajappan, K., Bates, M. G. D., Temple, I. P., Reichlin, T., Chen, Z., Balasubramaniam, R. N., Ronayne, C., Clarkson, N., Morgan, M., B Tags: Arrhythmias and sudden death Source Type: research
